Lisa Caperelli | VP of IR |
William Collier | President and CEI |
Michael Sofia | Chief Scientific Officer |
David Hastings | CFO |
Michael McElhaugh | COO |
Dennis Ding | Jefferies |
Charles Moore | Baird |
Thomas Yip | H.C. Wainwright |
Keay Nakae | Chardan |
Roy Buchanan | JMP Securities |
Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Corporation Fourth Quarter and Year-End 2022 Financial Results and Corporate Update Conference Call. At this time all participants are in a listen-only mode. After the speakers presentation there’ll be a question-and-answer session. [Operator Instructions].